Table 2 C-ARDS survivors meeting criteria for long Covid.
Meeting criteria for long COVID (n = 68) | Not meeting criteria for long COVID (n = 60) | |
|---|---|---|
Age, median (IQR) | 59 (51–67) | 62 (46–67) |
Gender (%) | ||
Female | 16 (24) | 21 (35) |
Male | 52 (76) | 39 (65) |
Race/ethnicity (%)* | ||
Black | 19 (33) | 15 (33) |
White | 15 (26) | 8 (17) |
Other | 23 (40) | 23 (50) |
Hispanic/Latinx | 38 (66) | 36 (75) |
Body mass index, median (IQR) | 29 (26–36) | 29 (26–33) |
Diabetes (%) | 17 (25) | 27 (45) |
Hypertension (%) | 30 (44) | 31 (52) |
Coronary artery disease (%) | 9 (13) | 7 (12) |
Symptom duration prior to admission, days (IQR) | 7 (5–10) | 7 (4–8) |
Median length of stay, days (IQR) | 51 (33–69) | 47 (33–61) |
PaO2/FiO2 Ratio, median (IQR) | 133 (84–185) | 152 (112–199) |
C-reactive protein, median (IQR) | 234 (137–300) | 272 (214–300) |
Defining symptom (%) | ||
Dyspnea | 29 (43) | |
Deconditioning | 27 (40) | |
Cough | 16 (24) | |
Fatigue | 9 (13) | |
Joint pain | 7 (10) | |
Peripheral neuropathy | 4 (6) | |
Headache | 4 (6) | |
Decreased appetite | 3 (4) | |
Loss of taste/smell | 1 (1) | |
Adjustment disorder | 1 (1) | |
Orthostatic hypotension | 1 (1) | |
Cognitive impairment | 1 (1) | |
Median time from diagnosis to post COVID-19 condition diagnosis, days (IQR) | 103 (94–125) | |
